KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Biomarin Pharmaceutical (BMRN) Net Margin: 2009-2025

Historic Net Margin for Biomarin Pharmaceutical (BMRN) over the last 14 years, with Sep 2025 value amounting to -3.96%.

  • Biomarin Pharmaceutical's Net Margin fell 1819.00% to -3.96% in Q3 2025 from the same period last year, while for Sep 2025 it was 16.82%, marking a year-over-year increase of 511.00%. This contributed to the annual value of 14.96% for FY2024, which is 803.00% up from last year.
  • Biomarin Pharmaceutical's Net Margin amounted to -3.96% in Q3 2025, which was down 113.59% from 29.14% recorded in Q2 2025.
  • Biomarin Pharmaceutical's Net Margin's 5-year high stood at 29.14% during Q2 2025, with a 5-year trough of -12.87% in Q4 2021.
  • Its 3-year average for Net Margin is 12.53%, with a median of 13.66% in 2024.
  • Per our database at Business Quant, Biomarin Pharmaceutical's Net Margin crashed by 17,353bps in 2021 and then soared by 1,968bps in 2022.
  • Biomarin Pharmaceutical's Net Margin (Quarterly) stood at -12.87% in 2021, then spiked by 1,283bps to -0.05% in 2022, then soared by 320bps to 3.15% in 2023, then surged by 1,357bps to 16.72% in 2024, then crashed by 1,819bps to -3.96% in 2025.
  • Its Net Margin stands at -3.96% for Q3 2025, versus 29.14% for Q2 2025 and 24.92% for Q1 2025.